Lidocaine Hydrochloride
Product Images NDC 0409-4904

6 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-4904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Lidocaine Hydrochloride (Lidocaine Hydrochloride 01)

Structural Formula Lidocaine Hydrochloride (Lidocaine Hydrochloride 01)
Chemical structure diagram of Lidocaine Hydrochloride, showing the aromatic ring with two methyl groups, an amide linkage, a diethylamino group, hydrochloride, and a water molecule. The structure depicts the molecular arrangement of the active ingredient Lidocaine Hydrochloride.*
FDA Label Image

Logo (Lidocaine Hydrochloride 02)

FDA Label Image

Principal Display Panel (20 mg/mL Syringe Label)

Principal Display Panel (20 mg/mL Syringe Label)
The label displays Lidocaine Hydrochloride Injection USP with a strength of 2% (100 mg/5 mL or 20 mg/mL) in a 5 mL single-dose syringe. It is intended for intravenous use for ventricular arrhythmias and is distributed by Hospira, Inc. The label includes dosing gradations, lot number, and expiration date fields.*
FDA Label Image

Principal Display Panel (20 mg/mL Syringe Carton)

Principal Display Panel (20 mg/mL Syringe Carton)
Packaging label for Lidocaine Hydrochloride Injection, USP 2%, 20 mg/mL strength in a 5 mL single-dose syringe. The label indicates a total of 100 mg per syringe, preservative-free formulation, distributed by Hospira, Inc. Instructions for aseptic technique use are illustrated. The product is labeled for intravenous use for ventricular arrhythmias.*
FDA Label Image

Principal Display Panel (10 mg/mL Syringe Label)

Principal Display Panel (10 mg/mL Syringe Label)
Label for Hospira, Inc. 1% Lidocaine Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL) in a 5 mL single-dose syringe. The label includes dosing marks, NDC 0409-9137-11, and states intravenous use for ventricular arrhythmias with pH between 5.0 to 7.0. Lot and expiration date placeholders are also shown.*
FDA Label Image

Principal Display Panel (10 mg/mL Syringe Carton)

Principal Display Panel (10 mg/mL Syringe Carton)
Label for Lidocaine Hydrochloride Injection, USP 1% (50 mg/5 mL or 10 mg/mL) single-dose syringe by Hospira, Inc. The 5 mL syringe contains 50 mg total lidocaine HCl, preservative-free, for intravenous use in ventricular arrhythmias. The label includes directions for aseptic technique, storage info, and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.